Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 5/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.48 |
| ▸ | ESR1 | P03372 | 2/20 | 0.48 |
| ▸ | AR | P10275 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13730471 | 1.00 | CYP19A1 (0.49) | CYP19A1MAOAMAOBPSMB5ESR2 | |
| SCHEMBL1071070 | 0.91 | ESR2 (0.51) | CYP19A1MAOAMAOBPSMB5ESR2 | |
| SCHEMBL126600 | 0.88 | AR (0.52) | CYP19A1MAOAMAOBPSMB5ESR2 | |
| SCHEMBL3696621 | 0.83 | KDM4E (0.54) | CYP19A1PSMB5ESR2ESR1HSD17B10 | |
| SCHEMBL28625919 | 0.82 | HSD17B1 (0.46) | CYP19A1ESR2ESR1HSD17B10ALDH1A1 | |
| SCHEMBL10360964 | 0.82 | MAOB (0.49) | CYP19A1MAOBALDH1A1 | |
| SCHEMBL6703209 | 0.82 | CYP19A1 (0.42) | CYP19A1ARALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL2283832 | 0.82 | CYP3A4 (0.49) | CYP19A1MAOAMAOBPSMB5ESR2 | |
| SCHEMBL5088610 | 0.81 | CYP19A1 (0.47) | CYP19A1MAOAMAOBPSMB5ESR2 | |
| SCHEMBL19746 | 0.81 | CYP19A1 (0.45) | CYP19A1MAOAMAOBARHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 440 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025091065-A1 | FLAVONOID COMPOSITION | GRETALS AUSTRALIA PTY LTD (AU) | 2025-05-08 | — | — | WO | claimed |
| US-20240373850-A1 | Compositions comprising resinous exudate metabolites from plants of the genus Adesmia, used to control and treat infections in plant crops; and methods for controlling infections in plant crops. | PONTIFICIA UNIV CATOLICA DE VALPARAISO (CL) | 2024-11-14 | — | — | US | claimed |
| CN-117242185-A | Biocatalytic preparation of dihydrochalcone | 西姆莱斯有限公司 | 2023-12-15 | — | — | CN | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| US-20230172901-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | GRETALS AUSTRALIA PTY LTD (AU) | 2023-06-08 | — | — | US | claimed |
| EP-4146194-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | Gretals Australia Pty Ltd (AU) | 2023-03-15 | — | — | EP | claimed |
| WO-2022221968-A1 | COMPOSITIONS COMPRISING RESINOUS EXUDATE METABOLITES FROM PLANTS OF THE GENUS ADESMIA, USED TO CONTROL AND TREAT INFECTIONS IN PLANT CROPS; AND METHODS FOR CONTROLLING INFECTIONS IN PLANT CROPS | PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO (CL) | 2022-10-27 | — | — | WO | claimed |
| WO-2021222987-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | GRETALS AUSTRALIA PTY LTD (AU) | 2021-11-11 | — | — | WO | claimed |
| US-11040079-B2 | Compositions derived from Galenia Africana and methods of use for cancer treatment | BIOPHARM NZ LIMITED (NZ) | 2021-06-22 | — | — | US | claimed |
| CN-112716933-A | Application of 7-hydroxyflavanone in preparation of medicine for promoting juvenile bone growth | 河南省洛阳正骨医院（河南省骨科医院） | 2021-04-30 | — | — | CN | claimed |
| EP-3558333-A1 | COMPOSITIONS DERIVED FROMGALENIA AFRICANA | Biopharm NZ Limited (NZ) | 2019-10-30 | — | — | EP | claimed |
| WO-2018116146-A1 | COMPOSITIONS DERIVED FROM GALENIA AFRICANA AND METHODS OF USE FOR CANCER TREATMENT | BIOPHARM NZ LIMITED (NZ) | 2018-06-28 | — | — | WO | claimed |
| US-20110020895-A1 | METHODS AND COMPOSITIONS FOR DETERMINING ISOMERASE ENZYMATIC ACTIVITY | SALK INSTITUTE FOR BIOLOGICAL STUDIES | 2011-01-27 | — | — | US | claimed |
| US-20080254519-A1 | Process for Producing Picolinic Acid Compounds | SHINDO KAZUTOSHI | 2008-10-16 | — | — | US | claimed |
| EP-1726645-A1 | PROCESS FOR PRODUCING PICOLINIC ACID COMPOUNDS | MARINE BIOTECHNOLOGY INSTITUTE CO., LTD. (JP) | 2006-11-29 | — | — | EP | claimed |
| US-20040096955-A1 | Methods and compositions for determining isomerase enzymatic activity | NATIONAL SCIENCE FOUNDATION | 2004-05-20 | — | — | US | claimed |
| WO-2002018604-A2 | METHODS AND COMPOSITIONS FOR DETERMINING ISOMERASE ENZYMATIC ACTIVITY | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2002-03-07 | — | — | WO | claimed |
| US-20260033492-A1 | Pest Repellents and Uses Thereof | SENSORYGEN INC (US) | 2026-02-05 | — | — | US | disclosed |
| US-4376123-A | Hexahydroazepinyloxy-chromones useful as antidepressants | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1983-03-08 | — | — | US | disclosed |
| EP-0031885-A1 | Basic ethers, pharmaceutical compositions containing them and process for their preparation | MERCK PATENT GmbH (DE) | 1981-07-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240373850-A1 | Compositions comprising resinous exudate metabolites from plants of the genus Adesmia, used to control and treat infections in plant crops; and methods for controlling infections in plant crops. | ERG28, RXFP4, CROCC | CYP19A1 2372/4885MAOA 2174/4885MAOB 2261/4885 |
| US-20260033492-A1 | Pest Repellents and Uses Thereof | F3, TFPI, FLI1 | CYP19A1 2958/4885MAOA 602/4885MAOB 1790/4885 |
| US-20080254519-A1 | Process for Producing Picolinic Acid Compounds | HPD, PAH, DHPS | CYP19A1 126/4885MAOA 187/4885MAOB 294/4885 |
| US-20230172901-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | MMP1, COL1A1, SERPINB1 | CYP19A1 3035/4885MAOA 2155/4885MAOB 2184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.